4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transsduction mediated by tyrosine kinases
A Standard patent application filed on 24 February 2000 credited to Himmelsbach, Frank ; Langkopf, Elke ; Blech, Stefan ; Metz, Thomas ; Solca, Flavio ; Jung, Birgit

Details

Application number :
32816  
Application type :
Standard  
Application status :
LAPSED  
Under opposition :
No  
Proceeding type :
 
Invention title :
4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transsduction mediated by tyrosine kinases  
Inventor :
Himmelsbach, Frank ; Langkopf, Elke ; Blech, Stefan ; Metz, Thomas ; Solca, Flavio ; Jung, Birgit  
Agent name :
Davies Collison Cave  
Address for service :
Level 15 1 Nicholson Street MELBOURNE VIC 3000  
Filing date :
24 February 2000  
Associated companies :
 
Applicant name :
Boehringer Ingelheim Pharma GmbH & Co. KG  
Applicant address :
Binger Str. 173 55216 Ingelheim am Rhein Germany  
Old name :
Boehringer Ingelheim Pharma KG  
Original Source :
Go  

Same Inventor